Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease
|
|
- Allyson Charles
- 8 years ago
- Views:
Transcription
1 Secondary Prevention and Rehabilitation Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease Daniela Lucini, MD, PhD, a Richard V. Milani, MD, b Giorgio Costantino, MD, a Carl J. Lavie, MD, b Alberto Porta, MS, PhD, a and Massimo Pagani, MD a Milan, Italy, and New Orleans, La Background Although cardiovascular rehabilitation and exercise training have substantial benefits in various ischemic heart disease (IHD) risk factors and subsequent prognosis after major IHD events, there is a paucity of information about its effects on autonomic regulation (such as heart rate variability [HRV] and baroreflex gain), particularly considering its arterial and cardiopulmonary components. Methods We studied 40 patients (aged 60 6 y) after major IHD events, including 29 who underwent a comprehensive phase II cardiac rehabilitation and exercise training program and 11 controls who did not attend cardiac rehabilitation. Specifically, we determined whether active training improves prognostic indices of autonomic regulation of the SA node and whether changes in baroreflex gain could be ascribed to the arterial or to the cardiopulmonary component of the overall arterial pressure/heart period baroreflex. Results Only patients with IHD undergoing active rehabilitation demonstrated a significant increase in R-R interval, in its variance, in overall gain of arterial pressure/heart period baroreflex ( ms/mm Hg to ms/mm Hg, P.001) and in peak oxygen consumption ( 2.45 ml/kg/min, P.001). Separate examination of the selective arterial and cardiopulmonary components showed that only the latter increased significantly ( ms/mm Hg to ms/mm Hg; P.01). Conclusions Cardiac rehabilitation is associated with significant improvements in autonomic markers of neural regulation of the SA node, such as increases in R-R variance and the gain of the overall spontaneous baroreflex, with specific improvements in the cardiopulmonary component as opposed to the arterial baroreflex component of this system. These improvements may further explain the reduction in morbidity and mortality noted after formal cardiac rehabilitation and exercise training programs. (Am Heart J 2002;143: ) Autonomic dysfunction, as evidenced by reduced heart rate variability and baroreflex gain, has strong adverse effects on subsequent clinical outcome in patients with ischemic artery disease (IHD), 1-4 offering a potential functional rationale to the beneficial effects of therapeutic modalities such as -adrenergic receptor From the a Centro di Ricerca sulla Terapia Neurovegetativa, Medicina Interna I, Ospedale L. Sacco, DiSP LITA Vialba, Centro Ricerche Cardiovascolari, CNR, Università di Milano, Milano, Italy, and the b Department of Cardiology, Ochsner Medical Institutions, New Orleans, La. Supported by Ministero Universita Ricerca Scientifica e Tecnologica (MURST), Agenzia Spaziale Italiana (ASI), and Interdisciplinary Research for Clinical and Experimental Advancement (IRCEA). Submitted April 2, 2001; accepted January 17, Reprint requests: Richard V. Milani, MD, FACC, Vice Chairman, Department of Cardiology, Ochsner Medical Institutions, 1514 Jefferson Highway, New Orleans, LA rmilani@ochsner.org 2002, Mosby, Inc. All rights reserved /2002/$ /1/ doi: /mhj blockade, which may be capable of ameliorating attending autonomic alterations. We and others have described the numerous benefits of cardiac rehabilitation and exercise training programs in patients with IHD and congestive heart failure (CHF), including improvements in exercise capacity, clinical and psychological factors, and marked reduction in subsequent major cardiac morbidity and mortality, including total mortality However, there is a paucity of information regarding the effects on autonomic regulation, and notably on baroreflex mechanisms, which have been reported to be either improved, unaffected, or depressed 17,18 by cardiac rehabilitation and exercise training. On the contrary, in other cardiovascular conditions, such as in hypertension, 11,19 consistent data suggest that exercise training improves baroreflex gain. These contradicting results might well depend on technical aspects such as the intensity and type of exercise training routines
2 978 Lucini et al American Heart Journal June 2002 Table I. Study population Cardiac rehab Control cardiopulmonary component of the overall arterial pressure/heart period baroreflex. No Age (y) * Sex (M/F) 24/5 8/3 Weight (kg) * Height (cm) Percent body fat Total cholesterol (mg/dl) * HDL cholesterol (mg/dl) * LDL cholesterol (mg/dl) * Triglycerides (mg/dl) Exercise capacity, estimated METs Glucose (mg/dl) VO 2 (ml/kg/min) LV end diastolic diameter (cm) Ejection fraction (%) Blockers (%) 18 (62) 6 (55) ACE inhibitors (%) 6 (21) 3 (27) Calcium antagonist (%) 9 (31) 2 (18) ASA (%) 16 (55) 8 (73) Diuretics (%) 4 (14) 2 (17) Data are presented as mean SE. *P.05 cardiac rehabilitation group versus control group. used or on the methods used to assess baroreflex gain. 20 A simplified open-loop linear model 21 is commonly used to approximate the arterial pressure/heart period relationship, in spite of the well-recognized closedloop properties of the intact circulation. The presence of several interacting influences, such as respiration and sympathetic activity, 22 may be particularly important in various disease conditions including IHD 1 and CHF, 23 reducing the accuracy of a simple linear open-loop model in assessing the arterial pressure/ heart period relationship. The application of a trivariate model 24 that uses the components of spontaneous beat-by-beat variability of the R-R interval, systolic arterial pressure, and respiration, provided a unitary view 20 of the arterial pressure/heart period relationship explicitly addressing respiratory influences. The advantage of this trivariate system is its ability to separate the indices of arterial and cardiopulmonary baroreflex gain, 25 as well as the factors influencing feed forward pathways. 26 In this study of vigorously treated stable patients with IHD, we assessed the effects of formal outpatient phase II cardiac rehabilitation and exercise training programs on parameters of autonomic function. Specifically, we determined whether active training improves prognostic indices of autonomic regulation of the SA node (heart rate variability [HRV] and spontaneous baroreflex gain) and whether changes in baroreflex gain could be ascribed to the arterial or to the Methods Study population This study involved 40 consecutive patients from Ochsner Medical Institutions, referred to the Cardiovascular Health Center for comprehensive phase II cardiac rehabilitation and exercise training after a major cardiac event, including myocardial infarction (MI), coronary artery bypass grafting (CABG), or percutaneous balloon angioplasty (PTCA). Patients were subdivided into 2 groups: 29 patients (15 CABG, 9 MI, 5 PTCA) attended and completed the 12-week outpatient phase II cardiac rehabilitation and exercise training programs (Cardiac Rehab group), and 11 patients (3 CABG, 4 MI, 4 PTCA) declined to participate in the program but agreed to participate as controls (Control group). All patients received statistically similar medical therapy including -adrenergic blocking agents, angiotensin-converting enzyme inihibitors, calcium-channel blockers, diuretics, lipid medications and aspirin, which were given for 4 weeks before study entry and were maintained throughout the study program (Table I). Protocol Protocol, data collection, and statistical analysis were performed as previously described. 5-8 Patients were referred to and participated in outpatient phase II cardiac rehabilitation lasting 12 weeks and consisting of 36 educational and exercise sessions. Each session consisted of approximately 10 minutes of warm-up exercises, including stretching and calisthenics, followed by 30 to 40 minutes of continuous upright aerobic and dynamic exercise (various combinations of walking, bicycling, jogging, rowing, etc), light isometric exercise (ie, hand weights), and approximately 10 minutes of cooldown stretching and calisthenics. Exercise intensity was prescribed individually so that the patient s heart rate was approximately 70% to 85% of the maximum heart rate and targeted below anaerobic threshold, which was determined on the entry cardiopulmonary stress test, or 10 to 15 beats per minute below the level of any exercise-induced symptomatic or silent myocardial ischemia. In addition to the supervised exercise sessions, all patients were encouraged to exercise approximately 1 to 3 times per week outside of the formal program. Each patient s exercise prescription was periodically adjusted to encourage a gradual increase in overall exercise performance. At baseline, patients were instructed to comply with the Phase I diet of the American Heart Association. Patients were frequently reinforced by physicians, dietitians, nurses, and exercise physiologists to comply with both the exercise and dietary portions of the program throughout its duration. Group sessions were held on educational aspects of IHD and psychological adaptation to this disease. Anthropometric and metabolic data, peak oxygen consumption (VO 2 ), and autonomic function were assessed at baseline (approximately 3-6 weeks after the cardiac event; average 4 weeks) and again one week after completing the cardiac rehabilitation and exercise training program. Ejection fraction was assessed by
3 American Heart Journal Volume 143, Number 6 Lucini et al 979 echocardiography in each patient only at baseline because left ventricular performance appears largely unaffected by exercise training in IHD. 27 Control group After completing the initial data collection, the control group subjects maintained their normal levels of daily physical activity. They received informational material and suggestions on how to improve their lifestyle, and no active intervention was performed. At the time of the second recording, verification of lack of significant exercise was obtained from patients through self report. Study of the autonomic control of the circulation On the day of the study, subjects were instructed to avoid alcohol and caffeinated beverages for the 12 preceding hours, to avoid heavy physical activity the day before, and to come to the laboratory between 7:00 AM and 12:30 PM, after a light breakfast. All subjects were carefully instructed about the study procedure and all gave informed consent to a protocol approved by the Ochsner Medical Institutions institutional review board. Patients were studied in resting conditions (lying down with 15 degree back support); after a 10- minute period to allow for stabilization, 10 minutes of data were obtained. Recorded variables By use of standard Ag-AgCl electrodes and a piezoelectric respiratory belt (PVF2, 3M, Austin, Tex), both the electrocardiogram (CM5) and the respiratory signal were monitored with a 2-way radiotelemetry system (Marazza, Monza-Milano, Italy). The arterial pressure waveform was continuously estimated noninvasively with a plethysmographic device (Finapres, Ohmeda, Englewood, Colo). Data were acquired on the hard disk of a personal computer equipped with an analogue-to-digital board (Data Translation, Marlboro, New Hampshire) with an acquisition rate of 300 samples/channel/ second. Data analysis The principles and software for data analysis have already been described in detail. 28,29 Briefly, from an electrocardiogram derived tachogram, an optimized autoregressive approach furnished the power and center frequency of low frequency (LF) and high frequency (HF) spectral components, in both absolute (ms 2 ) and normalized (nu) units. With this approach, the LF component of R-R interval variability, in nu, provides a quantitative index of sympathetic excitatory modulation of the SA node, and the HF component is a marker of vagal modulation. 28,29 The LF/HF is a convenient marker of sympathovagal interaction. The LF component of systolic arterial pressure variability provides a marker of sympathetic vasomotor modulation. 28,29 Spectral analysis was also performed on the respiratory signals to assess the main respiratory frequency. From the simultaneous analysis of arterial pressure and R-R interval variabilities, a frequency domain index ( lumped ) can be derived (a measure of the overall gain of the arterial pressure/heart period relationship that provides results similar to those obtained with the phenylephrine slope approach). 19 A trivariate model originally proposed by Baselli et al 24 was used to selectively evaluate the gain of the arterial baroreflex loop ( art ). This model describes the closed loop relationship between R-R interval, systolic arterial pressure variability and respiration by use of a generalized least square approach. 30 After identification, the transfer function describing the causal influences of systolic arterial pressure on R-R interval provides an estimate of the arterial baroreflex gain art. On the basis of recent studies indicating that a simple additive model applies to the relationship between arterial and cardiopulmonary components of baroreflex regulation of the SA node, 31 the difference between lumped and art was taken as an approximate indicator of the reflex influence of cardiopulmonary baroreceptor loops on beat-by-beat control of heart-period ( cp ). 20,25 Statistical analysis Data are presented as mean SEM. Significance of differences in data were assessed with 2-factor (group and time) analysis of variance for repeated measures, according to either the t test or Koch, by use of the Geisser-Greenhouse correction as appropriate. A P value.05 was considered significant. Results Study population At baseline (Table I), statistically significant differences were noted between cardiac rehabilitation and control patients regarding age, obesity indices, and plasma lipids. However, both groups were statistically similar in regards to sex, blood glucose, LV end-diastolic volume, ejection fraction, exercise capacity as assessed by peak VO 2, and pharmacologic treatments. After cardiac rehabilitation and exercise training, patients had statistically significant improvements in triglycerides ( mg/dl, P.02), and peak VO 2, which increased significantly ( ml/kg/min). Changes in VO 2 were significantly correlated with increases in R-R variance (P.05), but not with indices of baroreflex gain. Improvements in other parameters, however, were not statistically significant. There were no statistically significant changes noted over time in the control patients. Hemodynamics At baseline, R-R interval and systolic arterial pressure (SAP) values were similar in the 2 patient groups. After formal cardiac rehabilitation and exercise training, a significant increase in R-R interval was noted, whereas no significant changes were observed in SAP values. There were no changes in either R-R intervals or SAP values in control patients (Table II). Autonomic control of the circulation Spectral analysis. At baseline, there were no significant differences in spectral parameters between groups, with the exception of R-R interval variance,
4 980 Lucini et al American Heart Journal June 2002 Table II. Descriptive statistics of RR interval and systolic arterial pressure variabilities before and after cardiac (n 29) or sham (n 11) rehabilitation RR (ms) VAR RR (ms 2 ) LF RR (mm Hg 2 ) LF RR (nu) HF RR (mm Hg 2 ) HF RR (nu) LF/HF SAP (mm Hg) LF SAP (mm Hg 2 ) Respiratory frequency (Hz) Cardiac rehab group Before After * * Control group Before After Data are presented as mean SE. *P.05 before versus after. P.05 cardiac rehab group versus control group. Table III. Descriptive statistics of baroreflex indices before and after cardiac or sham rehabilitation lumped (ms/mm Hg) art (ms/mm Hg) cp (ms/mm Hg) Cardiac rehab group (n 29) Before After * * Control group (n 11) Before After Data are presented as mean SE. *P.05 before versus after. P.05 cardiac rehab group versus control group. which was greater in the younger control patients. After cardiac rehabilitation and exercise training, significant increases were noted in the R-R interval variance, reaching values slightly greater than those observed in the control group (Table II). Baroreflex gain. At baseline, a significant difference between groups was noted in lumped, which was greater in the younger control patients. After cardiac rehabilitation and exercise training programs, significant increases were noted in lumped, from ms/mm Hg to ms/mm Hg (P.001). On the other hand, this index diminished slightly in the control group. The index art, a marker of the arterial baroreflex gain, was unchanged in both active and control patients. Conversely, cp, a marker of cardiopulmonary baroreflex gain, increased significantly, from ms/mm Hg to ms/mm Hg (P.01), in the cardiac rehabilitation group and decreased slightly in the control group (Table III and Figure 1). Respiration. Respiratory rate and pattern, assessed with spectral analysis of respiratory movements, were not significantly different in the 2 groups considered at baseline, and were not modified by either cardiac or sham rehabilitation (Table II). Discussion This study shows significant improvements in parameters of autonomic function after formal phase II outpatient cardiac rehabilitation and exercise training programs, as indicated by significant increases in R-R, R-R variance, and in the gain of the arterial pressure/heart period relationship. This latter increase appears ascribable to a selective improvement of the cardiopulmonary component of the baroreflex while the arterial component remains unaffected. Because autonomic dysfunction is known to adversely affect clinical outcome in patients with cardiovascular diseases, 1,2 these improvements in autonomic regulation after cardiac rehabilitation may add to the other proven benefits of cardiac rehabilitation and exercise training in improving subsequent prognosis of these patients with IHD. It should be noted that the usual methods 21 used to assess baroreflex gain in a clinical setting are based on a simplified linear open loop model that only considers arterial reflexogenic areas as a sensory input. However, it is well recognized that the relationship between ar-
5 American Heart Journal Volume 143, Number 6 Lucini et al 981 Figure 1 Changes between pre- and postcardiac (open bars) or sham (dark bars) rehabilitation in total variance ( VAR), in the marker of the overall gain of the arterial pressure-heart period relationship ( lumped ), in the marker of the arterial baroreflex gain ( art ), and in the marker of cardiopulmonary baroreflex gain ( cp ). terial pressure and heart period is complex and derives from the interplay of several neural and non-neural mechanisms acting in a closed loop. 24,32 For instance, sympathetic 22 and cardiopulmonary afferents might play an important modulating role in baroreflex gain, whereas respiration may add an important bias because of its direct effects on cardiac vagal motoneurons, as indicated in the early description of the Oxford method. 21 On the basis of prior data from human investigations showing that an additive model (considering changes in carotid, aortic and cardiopulmonary pressures) accounts for the major fraction of R-R variability, 31 we have recently described a method to disentangle arterial from nonarterial (ie, mostly cardiopulmonary) components of the overall baroreflex gain. 20,25 This approach led to the observation, obtained in this investigation, of a selective improvement of the cardiopulmonary baroreflex gain after training in patients with IHD. The observed changes are unlikely to depend on changes in left ventricular performance, which appear to be largely unaffected by exercise training in patients with IHD. 27 Incidentally, left ventricular function, as assessed by ejection fraction, was similar at entry in our 2 patient groups. Extrapolating from data obtained in athletes, an improved cardiopulmonary baroreflex could be the result of an augmented inhibitory influence of cardiopulmonary receptors 33 possibly linked to the improved respiratory performance. Likewise, training induced an improved cardiac neuronal function, in the absence of changes in left ventricular performance, 34 in patients with CHF. A likely role of more powerful vagal mechanisms 35 after exercise training is further suggested by the increase in R-R interval and R-R variance observed in this study in the cardiac rehabilitation group. Notably, in this study, only insignificant changes were observed in the spectral profile of HRV, possibly reflecting the influence of maintained medical treatment as well as the fact that the exercise training routine was of only moderate intensity. 36 More intense training or more severe cardiac functional impairments at baseline might instead lead to a more apparent variation in spectral profile. For instance, Coats et al 10 showed a reduction in LF from elevated baseline values in patients with CHF who were subjected to a period of physical training. Opposite changes were observed for HF. In line with data from patients with CHF, 10 we also observed, in this investigation, that the improved exercise performance (assessed by increased peak VO 2 ) correlated with increases in R-R variance. However, the lack of correlation with other autonomic markers (such as baroreflex gain) and the nonsignificant variations in spectral profile induced by active training point to either an inhomogeneous influence of cardiac rehabilitation, or to the importance of baseline alterations in neurovegetative regulation mediated by heart failure. Although the exercise training component is often emphasized in discussions regarding cardiac rehabilitation, it should be recalled that the phase II outpatient cardiac rehabilitation program is a multifunctional risk factor prevention program that includes dietary and educational interventions, with emphasis on various psychological factors and stress management. 6,37 Although the role of these various components of the cardiac rehabilitation program were not addressed separately in this study, because mental stress can reduce baroreflex gain, 38 it is quite possible that the stress management component 39 may have contributed to the favorable results that we have described. Cardiac rehabilitation and exercise training programs provide benefits, in addition, on various psychological functions, especially depression, hostility, and overall psychological distress that might further improve prognosis. 6,37,40 Several study limitations need to be emphasized. First, all patients were not randomized, but referred to the cardiac rehabilitation program, which in itself raises the possibility of selection bias, although, for patients who have a cardiac event, there is an almost 100% referral rate to the cardiac rehabilitation pro-
6 982 Lucini et al American Heart Journal June 2002 grams at our institution. The control group represented patients who chose not to attend the program. Moreover all patients received standard medical therapy including -adrenergic blocking agents, angiotensin-converting enzyme inhibitors and calcium-channel blockers that could affect autonomic markers. 41 However, this is an unlikely major bias because treatment distribution was similar in the 2 groups and all patients maintained the same treatment throughout the study program. Finally, the control patients were younger, heavier, and had higher levels of total low-density lipoprotein and high-density lipoprotein cholesterol. However, most autonomic variables at baseline were similar in both groups, although the younger control patients had greater R-R interval variance and lumped compared with the treatment group. Nevertheless, the treatment group demonstrated marked improvements in many variables after the cardiac rehabilitation and exercise training program, whereas no significant changes were noted in the control group. Accordingly, we believe that our data suggest that in medically treated IHD patients, a standardized outpatient phase II cardiac rehabilitation and exercise training program produces beneficial effects not only on exercise capacity and plasma lipids, but also improvements in autonomic markers of neural regulation of the SA node, such as increase of R-R variance and of the gain of the overall spontaneous baroreflex. Furthermore, our data suggests that this type of cardiac rehabilitation selectively increases the cardiopulmonary component 25 of the arterial pressure and heart period relationship, whereas the arterial baroreflex component seems unaffected. These improvements in autonomic function after outpatient cardiac rehabilitation and exercise training may help to further explain the effects of this therapy to reduce subsequent clinical events and mortality, 9 which seem out of proportion to the rather modest improvements generally noted in the overall IHD risk profile. We thank Giovanna Macciò for typing assistance. We greatly appreciate the assistance of the cardiac rehabilitation staff at the Ochsner Heart and Vascular Institute, whose help was invaluable during patient care and data collection. References 1. La Rovere MT, Bigger JT, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction). Lancet 1998;351: Bigger JT Jr, Fleiss JL, Steinman RC, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85: Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93: Farrell TG, Odemuyiwa O, Bashir Y, et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 1992;67: Lavie CJ, Milani RV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 1997;79: Milani RV, Lavie CJ, Cassidy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 1996;132: Ali A, Mehra MR, Lavie CJ, et al. Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and normal lipid levels. Am J Cardiol 1998;82: , A8. 8. Church TS, Lavie CJ, Kirby GS, et al. Beneficial effects of cardiac rehabilitation and exercise training programs on blood rheology in patients with coronary artery disease [abstract]. Circulation 1997; 96:I O Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80: Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992;85: Somers VK, Conway J, Johnston J, et al. Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension. Lancet 1991;337: Halliwill JR, Taylor JA, Hartwig TD, et al. Augmented baroreflex heart rate gain after moderate-intensity, dynamic exercise. Am J Physiol 1996;270:R Hull SS, Vanoli E, Adamson PB, et al. Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation 1994;89: Sheldahl LM, Ebert TJ, Cox B, et al. Effect of aerobic training on baroreflex regulation of cardiac and sympathetic function. J Appl Physiol 1994;76: Leitch JW, Newling RP, Basta M, et al. Randomized trial of a hospital-based exercise training program after acute myocardial infarction: cardiac autonomic effects. J Am Coll Cardiol 1997;29: Lightfoot JT, Claytor RP, Torok DJ, et al. Ten weeks of aerobic training do not affect lower body negative pressure responses. J Appl Physiol 1989;67: Smith ML, Graitzer HM, Hudson DL, et al. Baroreflex function in endurance- and static exercise-trained men. J Appl Physiol 1988; 64: Bedford TG, Tipton CM. Exercise training and the arterial baroreflex. J Appl Physiol 1987;63: Pagani M, Somers V, Furlan R, et al. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 1988;12: Porta A, Baselli G, Rimoldi O, et al. Assessing baroreflex gain from spontaneous variability in conscious dogs: role of causality and respiration. Am J Physiol Heart Circ Physiol 2000;279: H Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res 1969;24:
7 American Heart Journal Volume 143, Number 6 Lucini et al Pagani M, Pizzinelli P, Bergamaschi M, et al. A positive feedback sympathetic pressor reflex during stretch of the thoracic aorta in conscious dogs. Circ Res 1982;50: Zucker IH, Wang W, Brandle M, et al. Baroreflex and cardiac reflex control of the circulation in pacing-induced heart failure. In: FG Spinale, editor. Pathophysiology of tachycardia-indiced heart failure. Armonk (NY): Futura; p Baselli G, Cerutti S, Civardi S, et al. Cardiovascular variability signals: towards the identification of a closed-loop model of the neural control mechanisms. IEEE Trans Biomed Eng 1988;35: Lucini D, Porta A, Milani R, et al. Assessment of arterial and cardiopulmonary baroreflex gains from simultaneous recordings of spontaneous cardiovascular and respiratory variability. J Hypertens 2000;18: Legramante JM, Raimondi G, Massaro M, et al. Investigating feedforward neural regulation of circulation from analysis of spontaneous arterial pressure and heart rate fluctuations. Circulation 1999; 99: Dubach P, Myers J, Dziekan G, et al. Effect of exercise training on myocardial remodeling in patients with reduced left ventricular function after myocardial infarction: application of magnetic resonance imaging. Circulation 1997;95: Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 1986;58: Malliani A, Pagani M, Lombardi F, et al. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: Baselli G, Porta A, Rimoldi O, et al. Spectral decomposition in multichannel recordings based on multivariate parametric identification. IEEE Trans Biomed Eng 1997;44: Desai T, Collins JC, Snell M, et al. Modeling of arterial and cardiopulmonary baroreflex control of heart rate. Am J Physiol 1997; 272:H Abboud FM, Thames MD. Interaction of cardiovascular reflexes. In: Sheperd JT, Abboud FM, Geiger SR, editors. Handbook of Physiology. vol 3. Bethesda (Md): American Physiological Society; p Takeshita A, Jingu S, Imaizumi T, et al. Augmented cardiopulmonary baroreflex control of forearm vascular resistance in young athletes. Circ Res 1986;59: Agostini D, Lecluse E, Belin A, et al. Impact of exercise rehabilitation on cardiac neuronal function in heart failure: an iodine-123 metaiodobenzylguanidine scintigraphy study. Eur J Nucl Med 1998;25: Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 1996;27: Furlan R, Piazza S, Dell Orto S, et al. Early and late effects of exercise and athletic training on neural mechanisms controlling heart rate. Cardiovasc Res 1993;27: Milani RV, Littman AB, Lavie CJ. Psychological factors influence prognosis of cardiovascular disease. In: Messerli FH, editor. Cardiovascular disease in the Elderly. 2nd ed. Norwell (Mass): Kluwer Academic Publishers; p Pagani M, Rimoldi O, Pizzinelli P, et al. Assessment of the neural control of the circulation during psychological stress. J Auton Nerv Syst 1991;35: Lucini D, Covacci G, Milani R, et al. A controlled study of the effects of mental relaxation on autonomic excitatory responses in healthy subjects. Psychosom Med 1997;59: Rozanski A, Blumenthal JA. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99: Lucini D, Mela GS, Malliani A, et al. Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: a study using spectral analysis of RR interval and systolic arterial pressure variability. J Cardiovasc Pharmacol 1997;29:
3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1
Post CABG Rehabilitation i Ahmed Elkerdany Professor of Cardiac Surgery Ain Shams University 1 Definition Cardiac rehabilitation services are comprehensive, long-term programs involving : medical evaluation.
More informationCardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better
Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.
More informationMedical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationMain Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
More informationThe Canadian Association of Cardiac
Reinventing Cardiac Rehabilitation Outside of acute care institutions, cardiovascular disease is a chronic, inflammatory process; the reduction or elimination of recurrent acute coronary syndromes is a
More informationListen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
More informationTherapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
More informationRemote Delivery of Cardiac Rehabilitation
Remote Delivery of Cardiac Rehabilitation Bonnie Wakefield, RN, PhD Kariann Drwal, MS Melody Scherubel, RN Thomas Klobucar, PhD Skyler Johnson, MS Peter Kaboli, MD, MS VA Rural Health Resource Center Central
More informationProtocol. Cardiac Rehabilitation in the Outpatient Setting
Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,
More informationKIH Cardiac Rehabilitation Program
KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 Feedback@kih.com.pk What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to
More informationKardiovaskuläre Erkrankungen ein Update für die Praxis, 22. Mai 2014 PD Dr. Matthias Wilhelm
Bewegungsbasierte kardiale Rehabilitation als 3. Säule fit für die Zukunft? Matthias Wilhelm Cardiovascular Prevention, Rehabilitation & Sports Medicine University Clinic for Cardiology Interdisciplinary
More informationMY TYPE 2 DIABETES NUMBERS
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
More informationGuidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
More informationCan Common Blood Pressure Medications Cause Diabetes?
Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately
More informationCentral Office N/A N/A
LCD ID Number L32688 LCD Title Cardiac Rehabilitation and Intensive Cardiac Rehabilitation Contractor s Determination Number L32688 AMA CPT/ADA CDT Copyright Statement CPT only copyright 2002-2011 American
More informationCardiac Rehabilitation CARDIAC REHABILITATION HS-091. Policy Number: HS-091. Original Effective Date: 3/16/2009
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationSection Four: Pulmonary Artery Waveform Interpretation
Section Four: Pulmonary Artery Waveform Interpretation All hemodynamic pressures and waveforms are generated by pressure changes in the heart caused by myocardial contraction (systole) and relaxation/filling
More informationCardiac Rehabilitation: Strategies Approaching 2020
ACC Banff 2015 Cardiac Rehabilitation: Strategies Approaching 2020 James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Libin Cardiovascular
More informationCardiovascular disease is the leading cause of morbidity
electronic health records Implementation of an Electronic Health Record with an Embedded Quality Improvement Program to Improve the Longitudinal Care of Outpatients with Coronary Artery Disease Allan G.
More informationPersonalisation of health in HF and CAD patients via closed loop systems
Personalisation of health in HF and CAD patients via closed loop systems // Compliance and Effectiveness in HF and CHD Closed loop Management // phealth 2009 Conference - Oslo Sergio Guillén Institute
More informationCardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
More informationAVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE
AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE To be completed by Staff Cardiologists at an adult cardiac institute/department. INSTRUCTIONS:
More informationSpecific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
More informationCardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone
James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest
More informationR.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney,
R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney, Australia Cardiac rehabilitation is an effective and safe
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationPrescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
More informationon behalf of the AUGMENT-HF Investigators
One Year Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure* Douglas
More informationCilostazol versus Clopidogrel after Coronary Stenting
Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background
More information2013 ACO Quality Measures
ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating
More informationHeart Rate and Physical Fitness
Heart Rate and Physical Fitness The circulatory system is responsible for the internal transport of many vital substances in humans, including oxygen, carbon dioxide, and nutrients. The components of the
More informationCardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy
Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:
More informationPhysiologic Mechanisms of Heart Rate Variability
Physiologic Mechanisms of Heart Rate Variability Harald M. Stauss, MD, PhD The University of Iowa, Iowa City, IA Demonstration of the ECG to the Royal Society in London, UK by Augustus Waller s bulldog,
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationAUTONOMIC NERVOUS SYSTEM AND HEART RATE VARIABILITY
AUTONOMIC NERVOUS SYSTEM AND HEART RATE VARIABILITY Introduction The autonomic nervous system regulates, among other things, the functions of the vascular system. The regulation is fast and involuntary.
More informationPresenter: Praveen N Pakeerappa, MBBS, PGY-3 Department of Physical Medicine and Rehabilitation, University of Kentucky, Lexington, KY
Outcomes in Phase II Cardiac Rehabilitation: A Retrospective Analysis Comparing Participants with CABG to Participants with Non-Surgical Interventions Praveen N Pakeerappa, Beth Cundiff, Robert Nickerson,
More informationCardiac Rehabilitation at AUBMC
Cardiac Rehabilitation at AUBMC Clinical Protocols and The Role of The Advanced Practice Nurse Presentation by: Mohamad Issa, MSN, BSN, BC- RN, AUBMC CCU OUTLINE Background on cardiovascular diseases History
More informationProtein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
More informationDiagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationTreating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
More informationSecondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
More informationCardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
More information4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts
Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.
More informationSummary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit
The Centers for Medicare & Medicaid Services' Office of Research, Development, and Information (ORDI) strives to make information available to all. Nevertheless, portions of our files including charts,
More informationRisk Factors for Fire Fighter Cardiovascular Disease
Risk Factors for Fire Fighter Cardiovascular Disease EXECUTIVE SUMMARY Prepared by: Jefferey L. Burgess, MD, MS, MPH Mel and Enid Zuckerman College of Public Health The University of Arizona The Fire Protection
More informationNEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH
NEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH Giovanni Esposito, MD, PhD Dipartimento di Cardiologia, Cardiochirurgia ed Emergenze Cardiovascolari Laboratorio di Emodinamica
More informationAfter acute myocardial infarction, diabetes CARDIAC OUTCOMES AFTER MYOCARDIAL INFARCTION IN ELDERLY PATIENTS WITH DIABETES MELLITUS
CARDIAC OUTCOMES AFTER MYOCARDIAL INFARCTION IN ELDERLY PATIENTS WITH DIABETES MELLITUS By Deborah Chyun, RN, PhD, Viola Vaccarino, MD, PhD, Jaime Murillo, MD, Lawrence H. Young, MD, and Harlan M. Krumholz,
More informationCardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease
Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification
More informationKinesiology Graduate Course Descriptions
Kinesiology Graduate Course Descriptions KIN 601 History of Exercise and Sport Science 3 credits Historical concepts, systems, patterns, and traditions that have influenced American physical activity and
More informationHypertension and Diabetes
Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas
More informationPerformance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly
More informationType II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More informationSuccess factors in Behavioral Medicine
Success factors in Behavioral Medicine interventions post myocardial infarction Depression Gunilla post myocardial Burell, PhD infarction Department of Public Health, Uppsala University, Sweden XIII Svenska
More informationIsabella Sudano & Franco Muggli
Swiss Hypertension Guidelines Isabella Sudano & Franco Muggli CoLaus, Swisshype ESC 2005 Dokumentenname Datum Seite 1 European Journal of Cardiovascular Prevention and Rehabilitation 2009 Guideline...
More informationClinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW
Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More information1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
More informationIschemic Heart Disease: Angina Pectoris
Ischemic Heart Disease: Angina Pectoris Robert J. Straka, Pharm.D. FCCP Associate Professor University of Minnesota College of Pharmacy Minneapolis, Minnesota, USA strak001@umn.edu Learning Objectives
More informationVascular Effects of Caffeine
Vascular Effects of Caffeine John P. Higgins MD, MBA, MPHIL, FACC, FACP, FAHA, FACSM, FASNC, FSGC Director of Exercise Physiology Memorial Hermann Sports Medicine Institute Chief of Cardiology, Lyndon
More informationRole of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
More informationRenovascular Hypertension
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
More informationDuration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More informationCardiac Rehabilitation and Intensive Cardiac Rehabilitation JA6850
Cardiac Rehabilitation and Intensive Cardiac Rehabilitation JA6850 Related CR Release Date: March 21, 2010 Revised Date Job Aid Revised: November 17, 2010 Effective Date: January 1, 2010 Implementation
More informationMilwaukee School of Engineering Gerrits@msoe.edu. Case Study: Factors that Affect Blood Pressure Instructor Version
Case Study: Factors that Affect Blood Pressure Instructor Version Goal This activity (case study and its associated questions) is designed to be a student-centered learning activity relating to the factors
More informationI. Current Cardiac Rehabilitation Requirements
CLIENT ADVISORY July 24, 2009 CMS Proposes Changes to Cardiac Rehabilitation Program Design and Physician Supervision Requirements The Centers for Medicare and Medicaid Services (CMS) recently published
More informationCase Study 6: Management of Hypertension
Case Study 6: Management of Hypertension 2000 Scenario Mr Ellis is a fit 61-year-old, semi-retired market gardener. He is a moderate (10/day) smoker with minimal alcohol intake and there are no other cardiovascular
More informationCoronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
More informationMISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY
MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY In order to improve the efficiency of PINNACLE Registry data analytics, a missing data analysis has been conducted on PINNACLE Registry data
More informationCardiac rehabilitation in the elderly Sara K. Pasquali, BS, Karen P. Alexander, MD, and Eric D. Peterson, MD, MPH Durham, NC
Curriculum in Cardiology Cardiac rehabilitation in the elderly Sara K. Pasquali, BS, Karen P. Alexander, MD, and Eric D. Peterson, MD, MPH Durham, NC Background Although patients 65 years old account for
More informationDrug Treatment in Type 2 Diabetes with Hypertension
Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk
More informationADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
More informationPreservation and Incorporation of Valuable Endoscopic Innovations (PIVI)
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) The American Society for Gastrointestinal Endoscopy PIVI on Endoscopic Bariatric Procedures (short form) Please see related White
More informationMarilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
More informationSection 8: Clinical Exercise Testing. a maximal GXT?
Section 8: Clinical Exercise Testing Maximal GXT ACSM Guidelines: Chapter 5 ACSM Manual: Chapter 8 HPHE 4450 Dr. Cheatham Outline What is the purpose of a maximal GXT? Who should have a maximal GXT (and
More informationClinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
More informationHow To Know Your Health
Interpreting fitnessgram Results FITNESSGRAM uses criterion-referenced standards to evaluate fitness performance. These standards have been established to represent a level of fitness that offers some
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationBASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
More informationHow To Treat Dyslipidemia
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
More informationAn Overview and Guide to Healthy Living with Type 2 Diabetes
MEETING YOUR GOALS An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS This brochure was designed to help you understand the health goals to live a healthy lifestyle with type
More informationThe Department of Vermont Health Access Medical Policy
State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 [Phone] 802-879-5903 Williston, VT 05495-2807 [Fax] 802-879-5963 www.dvha.vermont.gov Agency of Human Services The Department
More informationCARDIAC REHABILITATION Winnipeg Region Annual Report 2013-14
CARDIAC REHABILITATION Winnipeg Region Annual Report 2013-14 PROGRAM OVERVIEW The Cardiac Rehabilitation Program (CRP) operates out of two medical fitness facilities in Winnipeg, the Reh- Fit Centre and
More informationChapter Three Accountable Care Organizations
Chapter Three Accountable Care Organizations One of the most talked-about changes in health care delivery in recent decades is Accountable Care Organizations, or ACOs. Having gained the attention of both
More informationACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE
ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE V 9.0 eclinicalworks, 2013. All rights reserved Contents CONTENTS ACO SETUP 3 Demographics 3 ACO 12 4 ACO 13 6 ACO 14 7 ACO 15 8 ACO 16 9 ACO 17
More informationTime series analysis of data from stress ECG
Communications to SIMAI Congress, ISSN 827-905, Vol. 3 (2009) DOI: 0.685/CSC09XXX Time series analysis of data from stress ECG Camillo Cammarota Dipartimento di Matematica La Sapienza Università di Roma,
More informationCARDIAC REHABILITATION
Paul Peacock Cardiac Rehabilitation Nurse Friday, 4 August 2006 1 The rehab Team Chris Murphy Kate O Reilly Paul Peacock Increased to 2 FTEs March 06 Wellington & Kapiti Coast MDT involvement Friday, 4
More informationEvidence-Based Secondary Stroke Prevention and Adherence to Guidelines
Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Mitchell S.V. Elkind, MD, MS Associate Professor of Neurology Columbia University New York, NY Presenter Disclosure Information Mitchell
More informationBiofeedback treatment increases heart rate variability in patients with known coronary artery disease
Biofeedback treatment increases heart rate variability in patients with known coronary artery disease Jessica M. Del Pozo, PhD, a Richard N. Gevirtz, PhD, a Bret Scher, MD, b and Erminia Guarneri, MD,
More informationTYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
More informationCME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
More informationAdvanced Heart Failure & Transplantation Fellowship Program
Advanced Heart Failure & Transplantation Fellowship Program Curriculum I. Patient Care When on the inpatient Heart Failure and Transplant Cardiology service, the cardiology fellow will hold primary responsibility
More informationDual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute
Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical
More informationSUBCHAPTER 14F- CERTIFICATION OF CARDIAC REHABILITATION PROGRAMS
SUBCHAPTER 14F- CERTIFICATION OF CARDIAC REHABILITATION PROGRAMS SECTION.0100 RESERVED FOR FUTURE CODIFICAITON SECTION.0200 RESERVED FOR FUTURE CODIFICATION SECTION.0300 RESERVED FOR FUTURE CODIFICATION
More information6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology
Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die
More informationA randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation
A randomized, controlled trial comparing the efficacy of carvedilol vs. metoprolol in the treatment of atrial fibrillation Gabriel Sayer Lay Abstract: Atrial fibrillation is a common form of irregular,
More information